The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Short and long term effects of tibolone in postmenopausal women
|
---|---|
Published by |
John Wiley & Sons, Ltd, February 2012
|
DOI | 10.1002/14651858.cd008536.pub2 |
Pubmed ID | |
Authors |
Formoso, Giulio, Perrone, Enrica, Maltoni, Susanna, Balduzzi, Sara, D'Amico, Roberto, Bassi, Chiara, Basevi, Vittorio, Marata, Anna Maria, Magrini, Nicola, Maestri, Emilio |
Abstract |
Tibolone is an option available for the treatment of menopausal symptoms, based on short-term data on its efficacy. However, there is a need to consider the balance between the benefits and risks of tibolone as there are concerns about breast and endometrial cancer as well as stroke. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
Spain | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 1% |
Australia | 1 | 1% |
Brazil | 1 | 1% |
Canada | 1 | 1% |
Spain | 1 | 1% |
United States | 1 | 1% |
Unknown | 87 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 21 | 23% |
Student > Master | 11 | 12% |
Other | 10 | 11% |
Student > Ph. D. Student | 9 | 10% |
Student > Bachelor | 9 | 10% |
Other | 21 | 23% |
Unknown | 12 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 49 | 53% |
Nursing and Health Professions | 8 | 9% |
Agricultural and Biological Sciences | 6 | 6% |
Psychology | 5 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Other | 8 | 9% |
Unknown | 13 | 14% |